×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Meningitis Diagnostic Testing Market

ID: MRFR/HC/31508-HCR
111 Pages
Rahul Gotadki
October 2025

Rapport d’étude de marché sur les tests de diagnostic de la méningite par type de test (réaction en chaîne par polymérase, test immuno-enzymatique, tests de culture, ponction lombaire, tests sérologiques), par type d’échantillon (liquide céphalo-rachidien, sang, urine, biopsie tissulaire), par utilisateur final (hôpitaux, laboratoires de diagnostic, recherche universitaire), par type d’agent pathogène (bactérien, viral, fongique, parasitaire) et par région (Amérique du Nord, Europe, Amérique du Sud, Asie (Asie-Pacifique, Moyen-Orient et Afri... lire la suite

Partager
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Meningitis Diagnostic Testing Market
 Infographic
Purchase Options

Meningitis Diagnostic Testing Market Résumé

Les principales entreprises du marché Meningitis Diagnostic Testing Market incluent

Portée du rapport

Laisser un commentaire

FAQs

What is the current valuation of the Meningitis Diagnostic Testing Market as of 2024?

The Meningitis Diagnostic Testing Market was valued at approximately 0.9897 USD Billion in 2024.

What is the projected market size for the Meningitis Diagnostic Testing Market in 2035?

The market is projected to reach approximately 1.887 USD Billion by 2035.

What is the expected CAGR for the Meningitis Diagnostic Testing Market during the forecast period 2025 - 2035?

The expected CAGR for the Meningitis Diagnostic Testing Market during the forecast period 2025 - 2035 is 6.04%.

Which test type segment is anticipated to have the highest valuation in 2035?

The Polymerase Chain Reaction segment is expected to reach a valuation of approximately 0.6 USD Billion by 2035.

How does the valuation of cerebrospinal fluid testing compare to blood testing in 2035?

By 2035, cerebrospinal fluid testing is projected to be valued at around 0.7435 USD Billion, surpassing blood testing at approximately 0.5565 USD Billion.

What are the leading end-user segments in the Meningitis Diagnostic Testing Market?

Hospitals, Diagnostic Laboratories, and Academic Research are the primary end-user segments, with hospitals projected to reach 0.7435 USD Billion by 2035.

Which pathogen type is expected to dominate the market by 2035?

The bacterial pathogen type is anticipated to dominate the market, with a projected valuation of approximately 0.7434 USD Billion by 2035.

Who are the key players in the Meningitis Diagnostic Testing Market?

Key players include Roche, Abbott, Thermo Fisher Scientific, Siemens Healthineers, bioMerieux, Hologic, Cepheid, and QuidelOrtho.

What is the expected growth trend for enzyme-linked immunosorbent assay testing from 2024 to 2035?

The enzyme-linked immunosorbent assay segment is projected to grow from 0.25 USD Billion in 2024 to approximately 0.45 USD Billion by 2035.

How does the market for tissue biopsy testing compare to urine testing in 2035?

In 2035, tissue biopsy testing is expected to reach around 0.2145 USD Billion, while urine testing is projected at approximately 0.3725 USD Billion.

Télécharger l'échantillon gratuit

Veuillez remplir le formulaire ci-dessous pour recevoir un échantillon gratuit de ce rapport

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $ $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions